INNO-EXFO MCA 35 | Advanced Dermal Biorevitalization & Redensifying Peeling Matrix

The INNO-EXFO MCA 35 is a medical-grade, high-performance professional chemical resurfacing peel meticulously engineered to eliminate advanced signs of photoaging, reverse deep-tissue elastosis, and optimize epidermal-dermal thickness. Driven by a sophisticated structural synergy of Monochloroacetic Acid (MCA) and Salicylic Acid, this intensive clinical treatment operates at a foundational layer to trigger comprehensive dermal regeneration and cellular revitalization. Rather than merely causing aggressive surface shedding, MCA 35 induces a powerful biorevitalizing and redensifying effect across both the dermal and epidermal layers. It works dynamically to awaken sluggish fibroblasts, remodel broken elastic networks, and reverse skin atrophy (thinning). Throughout the cellular renewal cycle, this clinical peel smooths out stubborn lines, tightens slack architecture, and restores lost energy, leaving the face with an exceptionally dense, bouncy, and radiantly illuminated skin canvas.

____________________________________________________________________________________________________________________________________________________________________________

KEY TECHNICAL SPECIFICATIONS & BENEFITS

• Deploys a specialized 35% Monochloroacetic Acid matrix to penetrate deep into the dermis, forcing the rapid synthesis of fresh neo-collagen and structural proteins.

• Aggressively targets and corrects solar elastosis, restructuring damaged, tangled elastic fibers caused by chronic UV exposure to restore structural bounce.

• Reverses skin atrophy and tissue thinning by dramatically redensifying the extracellular matrix, leaving the skin noticeably thicker and more resilient.

• Utilizes Salicylic Acid as a keratolytic and anti-inflammatory guide, smoothing out coarse surface micro-texture while minimizing post-peel vascular irritation.

• Unleashes intense cellular biorevitalization, rapidly charging skin cell metabolism to clear sallow dullness and erase deep environmental fatigue.

• Professional clinical multi-vial configuration (5 x 5ml vials) precisely calibrated to maintain uncompromised chemical stability, sterility, and uniform dosing per peeling session.

____________________________________________________________________________________________________________________________________________________________________________

PRIMARY INDICATIONS & USE CASES

• Advanced chronological aging and photoaging profiles marked by deep lines, structural creases, and a lack of natural light reflection.

• Cutaneous solar elastosis displaying a loss of recoil, crepey skin texture, and gravity-induced sagging.

• Skin atrophy and epidermal thinning requiring high-level clinical redensifying and foundational tissue rebuilding.

• Professional backbar peeling treatments seeking an elite, low-downtime biorevitalizing solution that delivers the deep results of a medium-depth peel with maximum patient comfort.

____________________________________________________________________________________________________________________________________________________________________________

FREQUENTLY ASKED QUESTIONS

Q: What makes INNO-EXFO MCA 35 a "biorevitalizing" peel compared to traditional chemical peels?

A: Traditional chemical peels often focus primarily on stripping away the outer layers of the epidermis, which can lead to extensive peeling, redness, and social downtime. INNO-EXFO MCA 35 functions as a bio-remodeling treatment. While it gently refines the surface, its primary objective is to cross into the deeper dermal layers to deliver an energetic signal directly to your fibroblasts. It forces your skin to rebuild its internal structure from the inside out, providing a dramatic plumping and tightening effect with minimal surface disruption.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: How do Chloroacetic Acid and Salicylic Acid work in harmony during this treatment?

A: These two clinical acids act as a highly efficient resurfacing and remodeling team. Chloroacetic Acid acts as a powerful dermal regenerator, stepping deep into the matrix to alter cellular pathways and trigger rapid tissue redensification. Salicylic Acid acts as a lipophilic beta-hydroxy acid that quickly breaks down dead surface lipids, allowing the Chloroacetic Acid to penetrate with absolute uniformity. Furthermore, Salicylic Acid's innate anti-inflammatory properties help soothe the surrounding tissue, ensuring a smooth, highly controlled application.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: How precisely does this formula treat skin atrophy and elastosis?

A: Skin atrophy (thinning) and elastosis (the degradation of elastic fibers) occur when chronological aging and UV damage deplete your skin's structural reservoirs. MCA 35 intercepts this decline by flooding the tissue with a restorative cellular signal. This signal forces the body to synthesize dense waves of Hyaluronic Acid, Type I Collagen, and fresh elastin fibers. This thickens the dermal mattress, lifts hollow areas, and snaps loose, crepey skin back into a tight, firm alignment.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: What type of post-peel shedding and downtime should a patient expect after an MCA 35 session?

A: Because this advanced formula focuses its active therapeutic energy within the deeper dermal layers rather than aggressively frying the epidermis, the downtime is remarkably low. Patients will not experience the heavy, raw, or sheet-like skin peeling typically associated with deep medical peels. Instead, they may observe very mild, uniform micro-flaking or dryness between days 3 and 5 as old skin cells naturally desquamate, which can easily be managed with a clinical recovery cream.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: What is the packaging setup, and what is the standard professional administration protocol?

A: Each professional box contains exactly 5 sterile, single-use 5ml vials to ensure absolute potency and chemical integrity for every treatment. Because dermal redensification and elastosis repair operate on a cumulative biological timeline, a single session is not enough. The standard clinical protocol typically consists of a structured series of 3 to 5 professional sessions, spaced precisely 14 to 21 days apart, administered strictly by a licensed clinician using targeted manual massage or transdermal delivery techniques.